WEST HARRISON, N.Y.--(BUSINESS WIRE)--BioSante Pharmaceuticals Inc. (NASDAQ:BPAX) was recently highlighted in an article that appeared in the December 18, 2007 first issue of Flaherty Special Situations Newsletter published by Flaherty Financial News Inc. The piece examined the company’s Phase III clinical development of LibiGel and its ongoing corporate strategy. Titled, “Betting on Sexual Satisfaction for 2008,” the newsletter article addresses that there are three products on the market including Viagra that enhance sexual satisfaction for U.S. men, but not one for women. BioSante’s ambitious goal: First to market in the U.S. treatment with a product to alleviate Female Sexual Dysfunction –a huge $2 billion unmet medical need.
